CLINICAL_TRIALS
trial_result
· 2017-09-20
Clinical Trial Update: A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients [Phase 3]
Summary
Phase 3 trial comparing the biosimilar FKB327 to Humira in rheumatoid arthritis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujifilm Kyowa Kirin Biologics Co., Ltd. | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2017-09-20